Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Finasteride discontinuation increases sperm count in men.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Uterine transplants for transgender women are feasible but need more research.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Skin aging reflects overall body aging and can indicate internal health conditions.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.